iShares MSCI Philippines ETF (EPHE) is an exchange-traded fund that seeks to track the investment results of the MSCI Philippines IMI 25/50 Index, a free float-adjusted market capitalization-weighted index designed to measure the performance of the broad Philippine equity market. The fund provides targeted exposure to Philippine equities across diversified sectors including financials, industrials, real estate, utilities, consumer staples, and telecommunications; its portfolio holds approximately 38 stocks with top holdings such as International Container Terminal Services (17%), BDO Unibank (10%), SM Prime Holdings (7%), Manila Electric (5%), and Metropolitan Bank and Trust (5%). EPHE invests at least 80% of its assets in component securities of the underlying index or investments with similar economic characteristics, employing a representative sampling technique to replicate index performance while managing trading costs and tracking error; it offers growth and value stocks across various market capitalizations.
Launched on September 28, 2010, and managed by BlackRock Fund Advisors under iShares Trust, a series of BlackRock, Inc., EPHE is domiciled in the United States with primary operations focused on the Philippine stock market. The fund trades on NYSE Arca and targets investors seeking emerging market exposure to the Philippines, a key Southeast Asian economy; as of late 2025, it manages approximately $100 million in assets under management with an expense ratio of 0.59%.
In recent years, EPHE transitioned prior to December 1, 2020, from tracking an uncapped version of the MSCI Philippines IMI Index to the capped MSCI Philippines IMI 25/50 Index, which applies concentration limits of 25% per issuer and 50% aggregate for issuers over 5% to enhance diversification and comply with U.S. tax regulations. The fund undergoes quarterly index rebalancing to reflect market changes, with ongoing portfolio adjustments as evidenced by updated holdings data through October 2025; no major acquisitions, partnerships, funding rounds, or product launches specific to EPHE have been reported in the last 1-2 years.